In addition, matrix metalloproteinase-9 (MMP-9), which is involved in dendritic spine maturation and synapse formation, and is increased in FXS, can be inhibited by minocycline treatment, a tetracycline analogue. This evidence concerns the gene MMP9 and fragile X syndrome.